Bullous Pemphigoid (BP) Recruiting Phase 2 Trials for Ixekizumab (DB11569)

Also known as: Pemphigoid, Bullous / Bullous Pemphigoid / Pemphigoid / Bullous pemphigoid NOS

IndicationStatusPhase
DBCOND0074370 (Bullous Pemphigoid (BP))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03099538Ixekizumab in the Treatment of Bullous PemphigoidTreatment